Ident. | Authors (with country if any) | Title |
---|
000186 (2011) |
Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada] | Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts |
000281 (2011) |
Nick H. G. Holford [Nouvelle-Zélande] ; John G. Nutt [États-Unis] | Interpreting the results of Parkinson's disease clinical trials: Time for a change |
000566 (2010) |
Marcus M. Unger [Allemagne] ; Katja Hattemer [Allemagne] ; Jens C. Möller [Allemagne] ; Katrin Schmittinger [Allemagne] ; Katharina Mankel [Allemagne] ; Karla Eggert [Allemagne] ; Konstantin Strauch [Allemagne] ; Johannes J. Tebbe [Allemagne] ; Boris Keil [Allemagne] ; Wolfgang H. Oertel [Allemagne] ; Johannes T. Heverhagen [Allemagne] ; Susanne Knake [Allemagne] | Real‐time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's disease |
000818 (2010) |
Gennarina Arabia [Italie] ; Maurizio Morelli [Italie] ; Sandra Paglionico [Italie] ; Fabiana Novellino [Italie] ; Maria Salsone [Italie] ; Laura Giofrè [Italie] ; Giusi Torchia [Italie] ; Giuseppe Nicoletti [Italie] ; Demetrio Messina [Italie] ; Francesca Condino [Italie] ; Pierluigi Lanza [Italie] ; Olivier Gallo [Italie] ; Aldo Quattrone [Italie] | An magnetic resonance imaging T2*‐weighted sequence at short echo time to detect putaminal hypointensity in Parkinsonisms |
000982 (2009) |
Sabine Skodda [Allemagne] ; Heiko Rinsche [Allemagne] ; Uwe Schlegel [Allemagne] | Progression of dysprosody in Parkinson's disease over time—A longitudinal study |
000B71 (2009) |
Sanne Boesveldt [Pays-Bas] ; Cornelis J. Stam [Pays-Bas] ; Dirk L. Knol [Pays-Bas] ; Jeroen P. A. Verbunt [Pays-Bas] ; Henk W. Berendse [Pays-Bas] | Advanced time‐series analysis of MEG data as a method to explore olfactory function in healthy controls and Parkinson's disease patients |
000E73 (2008) |
Peter A. Lewitt [États-Unis] ; M. Guttman [Canada] ; James W. Tetrud [États-Unis] ; Paul J. Tuite [États-Unis] ; Akihisa Mori [Japon] ; Philip Chaikin [États-Unis] ; Neil M. Sussman [États-Unis] | Adenosine A2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005) |
000F27 (2007) |
Fabio Blandini [Italie] ; Giovanna Levandis [Italie] ; Eleonora Bazzini [Italie] ; Giuseppe Nappi [Italie] ; Marie-Therese Armentero [Italie] | Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old model |
001222 (2006) |
Kenichi Sato [Japon] ; Taku Hatano [Japon] ; Kazuo Yamashiro [Japon] ; Maki Kagohashi [Japon] ; Kenya Nishioka [Japon] ; Nana Izawa [Japon] ; Hideki Mochizuki [Japon] ; Nobutaka Hattori [Japon] ; Hideo Mori [Japon] ; Yoshikuni Mizuno [Japon] | Prognosis of Parkinson's disease: Time to stage III, IV, V, and to motor fluctuations |
001543 (2005) |
| A non linear analysis of human gait time series based on multifractal analysis and cross correlations |
001557 (2004) |
Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis] | Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3‐month, randomized, placebo‐controlled study |
001560 (2004) |
Anthony E. Lang [Canada] ; José A. Obeso [Espagne] | Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease |
001604 (2004) |
Alessandro Buccolieri [Italie] ; Laura Avanzino [Italie] ; Lucio Marinelli [Italie] ; Carlo Trompetto [Italie] ; Roberta Marchese [Italie] ; Giovanni Abbruzzese [Italie] | Muscle relaxation is impaired in dystonia: A reaction time study |
001704 (2003) |
Per-Arne Fall [Suède] ; Avin Saleh [Suède] ; Mats Fredrickson [Suède] ; Jan-Edvin Olsson [Suède] ; Ann-Kathrine Granérus [Suède] | Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9‐year follow‐up |
001759 (2003) |
Yassine Darbaky [France] ; Claude Forni [France] ; Marianne Amalric [France] ; Christelle Baunez [France] | High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task |
001A64 (2001) |
Ruth Hardoff [Israël] ; Michael Sula [Israël] ; Ada Tamir [Israël] ; Adrian Soil [Israël] ; Avi Front [Israël] ; Samich Badarna [Israël] ; Silvia Honigman [Israël] ; Nir Giladi [Israël] | Gastric emptying time and gastric motility in patients with Parkinson's disease |
001D14 (1999) |
Jack Jiang [États-Unis] ; Emily Lin [États-Unis] ; Boris Sheynin [États-Unis] ; David G. Hanson [États-Unis] | Voice target time in Parkinson’s disease: A preliminary report |
001D58 (1999) |
Claudia Schwab [Canada] ; Michael Schulzer [Canada] ; John C. Steele ; Patrick L. Mcgeer [Canada] | On the survival time of a tangled neuron in the hippocampal CA4 region in parkinsonism dementia complex of Guam |
002126 (1996) |
C. Kirollos ; A. Charlett ; S. G. Bowes ; A. G. Purkiss ; C. J. A. O Eill ; C. Weller ; J. Dickins ; G. Faulkner ; P. W. Nicholson ; W. B. Hunt ; R. J. Dobbs ; S. M. Dobbs | Time course of physical and psychological responses to selegiline monotherapy in newly diagnosed, idiopathic parkinosonism |
002127 (1996) |
M. Rodríguez [Espagne] ; M. Sabaté [Espagne] ; E. Troncoso [Espagne] | Time and frequency domain analysis for the assessment of heart autonomie control in Parkinson's disease |
002290 (1995) |
Tetsuo Yanagawa [Japon] ; Makoto Hirai [Japon] ; Hiroshi Hayashi [Japon] ; Hiroaki Sano [Japon] ; Yasushi Tomita [Japon] ; Yasuya Inden [Japon] ; Hidehiko Saito [Japon] | QRST time integral values in 12-lead electrocardiograms before and after radiofrequency catheter ablation in patients with Wolff-Parkinson-White syndrome |